Rock Springs Capital Management’s Bicara Therapeutics BCAX Stock Holding History

Rock Springs Capital Management’s Portfolio BCAX Stock Details BCAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.73M	Buy	489,095 +60,000	+14%	+$1.03M	0.57%	49
2025 Q4	$7.22M	Buy	429,095 +58,429	+16%	+$998K	0.37%	61
2025 Q3	$5.85M	Buy	370,666 +34,596	+10%	+$387K	0.34%	63
2025 Q2	$3.12M	Hold	336,070	–	–	0.19%	71
2025 Q1	$4.38M	Sell	336,070 -109,905	-25%	-$1.46M	0.25%	67
2024 Q4	$7.77M	Hold	445,975	–	–	0.3%	68
2024 Q3	$11.4M	Buy	+445,975	New	+$11.4M	0.37%	62

Other funds holding BCAX

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return